Improved brimonidine compositions for treating erythema

Details Improved brimonidine compositions for treating erythema Improved brimonidine compositions for treating erythema

A - Human Necessities

61

K

A61K 31/498 (2006.01) A61P 17/00 (2006.01)

Patent

CA 2698680

The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a pharmaceutically acceptable carrier such as a gel or cream. The invention also relates to a method and/or use of treating erythema in a patient with rosacea by administering the composition of the invention to the site of erythema on the skin of the patient.

La présente invention concerne une composition pharmaceutique comprenant du tartrate de brimonidine, entre environ 0,17 pour cent en poids et environ 0,19 pour cent en poids dans un vecteur pharmaceutiquement acceptable comme un gel ou une crème. L'invention concerne également un procédé ou une utilisation du traitement de l'érythème chez un patient ayant une acné rosacée en administrant la composition de l'invention sur le site de l'érythème sur la peau du patient.

Affiliated with

Also associated with

Rating

Improved brimonidine compositions for treating erythema does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved brimonidine compositions for treating erythema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved brimonidine compositions for treating erythema will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1659321